UE LifeSciences
Breast Cancer is disproportinately affecting all fast growing economies and developing regions around the world.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD7—10m (Dealroom.co estimates Oct 2016.)
Philadelphia Pennsylvania (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$880k | Grant | ||
N/A | $500k | Convertible | |
$3.0m | Series A | ||
$1.2m | Early VC | ||
N/A | $480k | Seed | |
Total Funding | CAD8.3m |
Related Content
Recent News about UE LifeSciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.